Cancer R&D 2024 has wrapped up successfully. We’re grateful for your interest and interaction with Alfa Cytology. We’re eager to continue providing our expertise in cancer drug development. Let’s look back on these memorable moments!
Learn MoreCell lines are widely used as model cells for normal or brain tumor tissues in research and drug development. To avoid mislabeling or replacement of cell lines by cells from other individuals, tissue, or germline sources, it is necessary to perform cell line assays. Short tandem repeat (STR) genotyping has been applied as the gold standard for cell identification by authorities.
Alfa Cytology offers a wide range of services including STR-based cell line identification and mycoplasma detection, where alleles on the STR locus can be distinguished by the number of copies of repeats in the PCR amplified region. We match the resulting STR typing results with STR data of cell lines from multiple databases to derive the name of the cell line to which the sample belongs or possible cross-contamination.
Project | Content | Sample requirements |
STR identification of human-derived cell lines | Customer-supplied human-derived cell sample (cell line or genomic DNA) |
|
Cell germline identification | ||
Cell recovery and culture | Cell recovery and expansion of culture | |
Mycoplasma testing | The customer provides cell supernatant | Culture for 48h-72 h, and cell density at least 80 %, volume ≥ 1 mL |
Alfa Cytology can provide identification services for human-derived brain tumor cells and mouse cells with reliable data and short cycle time. We will deliver a written report of the assay results at the end of the project, including cell STR typing data, the presence of multiple alleles (cross-contamination), and a map of STR typing. Please contact our staff to submit your project requirements.